Vaporization of perfluorocarbon droplets using optical irradiation by Strohm, Eric et al.
Vaporization of perfluorocarbon droplets using 
optical irradiation 
Eric Strohm,
1 Min Rui,
1 Ivan Gorelikov,
2 Naomi Matsuura,
2 and Michael Kolios
1,* 
1Department of Physics, Ryerson University, Toronto, Ontario M5B 2K3, Canada 
2Imaging Research, Sunnybrook Health Sciences Centre, Toronto, Ontario M4N 3M5, Canada 
*mkolios@ryerson.ca 
Abstract: Micron-sized liquid perfluorocarbon (PFC) droplets are currently 
being  investigated  as  activatable  agents  for  medical  imaging  and  cancer 
therapy. After injection into the bloodstream, superheated PFC droplets can 
be vaporized to a gas phase for ultrasound imaging, or for cancer therapy 
via targeted drug delivery and vessel occlusion. Droplet vaporization has 
been previously demonstrated using acoustic methods. We propose using 
laser  irradiation  as  a  means  to  induce  PFC  droplet  vaporization  using  a 
method we term optical droplet vaporization (ODV). In order to facilitate 
ODV  of  PFC  droplets  which  have  negligible  absorption  in  the  infrared 
spectrum,  optical  absorbing  nanoparticles  were  incorporated  into  the 
droplet. In this study, micron-sized PFC droplets loaded with silica-coated 
lead sulfide (PbS) nanoparticles were evaluated using a 1064 nm laser and 
ultra-high frequency photoacoustic ultrasound (at 200 and 375 MHz). The 
photoacoustic  response  was  proportional  to  nanoparticle  loading  and 
successful  optical  droplet  vaporization  of  individual  PFC  droplets  was 
confirmed  using  photoacoustic,  acoustic,  and  optical  measurements.  A 
minimum laser fluence of 1.4 J/cm
2 was required to vaporize the droplets. 
The  vaporization  of  PFC  droplets  via  laser  irradiation  can  lead  to  the 
activation of PFC agents in tissues previously not accessible using standard 
ultrasound-based techniques. 
©2011 Optical Society of America 
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1. Introduction 
Perfluorocarbons (PFCs) are non-toxic, chemically and biologically inert compounds [1] with 
unique  physical  properties  that  enable  their  use  in  a  wide  range  of  medical  applications. 
Applications  include  using  PFCs  as  contrast  agents  in  X-ray  computed  tomography  [2], 
magnetic resonance imaging [3] and ultrasound imaging [4], as blood substitutes [5], and for 
cancer therapy via targeted drug delivery [6] and vessel occlusion [7]. 
PFC droplets made from perfluoropentane (PFP, C5F12) are currently being investigated as 
externally activatable contrast agents for the detection and treatment of cancer. Despite its low 
boiling point (29°C at 1 atm), micron-sized (1-5 µm) PFP droplets can circulate within the 
body in a superheated state [8] after intravenous injection. PFP droplets have poor ultrasound 
contrast due to their acoustic impedance which is similar to that of the surrounding tissue, 
therefore  droplets  must  be  converted  to  gas  bubbles  to  enable  their  use  as  an  effective 
ultrasound contrast agent. In therapeutic applications, the increase in the droplet volume upon 
conversion to a bubble has been used to occlude blood vessels [7], and the droplets can also 
be used as drug delivery vehicles [9]. Typically, the conversion from droplets to bubbles is 
induced via ultrasound irradiation once a threshold pressure is achieved [10]. In this approach 
however, large peak negative ultrasonic pressures that may be harmful to normal surrounding 
tissue  (e.g.,  10  to  13  MPa  at  approximately  3.0  MHz  in  canine  kidney  [11])  have  been 
reported during transcutaneous acoustic droplet conversion (ADV). Also, ultrasound beams 
cannot  effectively  penetrate  gaseous  enclosures  in  the  human  body,  such  as  the  lungs. 
Therefore, another method is required to induce the therapeutic function of the droplets in 
these locations. 
We suggest using laser light to activate the droplets. Near-infrared light is well-suited to 
medical imaging and therapy, as this wavelength range has good tissue penetration depth and 
results in low photoacoustic background signals from tissue and blood in-vivo. The use of 
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could not. Moreover, a judicious choice of laser wavelength and light absorbing structure 
could offer the opportunity for the droplet to be used either as a photoacoustic contrast agent 
and/or  as  a  therapeutic  agent.  For  example,  different  optical  absorbers  with  different 
absorption coefficients could be used so that one wavelength induces a photoacoustic signal, 
while another triggers vaporization. Pulse-echo acoustic measurements could be used after 
vaporization to detect the location and/or number of the formed bubbles. PFC droplets could 
therefore  be  used  as  a  dual-contrast  agent  for  contrast  enhanced  imaging  and/or  cancer 
therapy:  using  photoacoustic  imaging  to  determine  the  locations  of  the  agents  before  the 
therapeutic intervention, and then ultrasound imaging after the payload delivery (provided that 
an acoustic path is available). However, liquid PFC has negligible absorption in the infrared 
region  of  the  spectrum  [12]  and  laser-induced  optical  droplet  vaporization  (ODV)  is  not 
possible.  Thus,  we  propose  to  facilitate  ODV  by  incorporating  infrared  absorbing  PbS 
nanoparticles  into  PFC  droplets.  PbS  nanoparticles  are  introduced  in  this  study,  however 
nanoparticles made of other optical absorbing materials, such as gold, iron oxide or carbon, 
could potentially be used. 
In this paper we demonstrate that a photoacoustic signal can be measured from micron-sized 
PFC droplets containing PbS nanoparticles before vaporization. The photoacoustic signal of 
droplets made with two different nanoparticle concentrations was correlated to the droplet 
absorption  coefficient,  showing  that  the  absorption  coefficient  can  be  controlled  by  the 
amount of nanoparticles used during droplet manufacturing. We then demonstrate that laser 
light  may  be  used  to  vaporize  nanoparticle-loaded  PFC  droplets  when  irradiated  above  a 
threshold laser fluence, and confirm that the resulting bubbles can be detected via ultrasound 
methods. 
2. Theory 
Liquid PFC droplets are optically transparent and have negligible absorption in the infrared 
spectrum, therefore optically absorbing nanoparticles must be incorporated into the droplet to 
facilitate adequate energy absorption. When irradiated by a pulsed laser, the nanoparticles 
undergo a rapid temperature increase, which subsequently heat the surrounding PFC liquid 
while simultaneously producing an ultrasound pressure wave (the photoacoustic signal). We 
assume a uniform distribution of nanoparticles within the droplet, and the droplet is optically 
transparent  to  allow  equal  and  instantaneous  heating  of  each  nanoparticle.  Moreover,  we 
assume that the entire droplet  will undergo a rapid uniform thermoelastic expansion.  The 
pressure resulting from the expansion of a spherical liquid droplet is [13] 
  0 ( ) ( ), a p q I A q   =    (1) 
where 
  
2 (sin cos )/
( ) ,
( / ) (1 )(sin / ) cos sin
iq d
p
iac q q q q
A q e
C r a q q q ic q
τ β
ρ ρ
− −
=
− − +
   (2) 
where µa is the droplet absorption coefficient, I0 is the laser intensity, a is the droplet radius, cd 
is  the  sound  velocity  in  the  droplet,  Cp  is  the  heat  capacity,  β  is  the  thermal  expansion 
coefficient, and ρ and c are the ratios of the density and sound velocity between the droplet 
and coupling fluid, respectively. The time τ and frequency q are redefined as dimensionless 
quantities where q = 2πfa/cd and τ = (v/a)[t-(r-a)/cf] is the delay time from the radius of the 
droplet, where cf is the sound velocity in the coupling fluid [13]. In Eq. (1), the photoacoustic 
pressure amplitude depends on the combined effects of the bulk properties of the droplet and 
the effective absorption coefficient µa of the droplet. Previous work showed good agreement 
of the ultrasound spectral features predicted by the model [Eqs. (1) and (2)] and photoacoustic 
measurements  of  micron-sized  PFC  droplets  [14].  For  efficient  photoacoustic  signal 
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where d is the diameter and α is the thermal diffusivity of the droplet [15]. For a typical 1 µm 
diameter  liquid  perfluorocarbon  droplet,  the  thermal  and  stress  confinement  times  are 
approximately 8 µs and 2 ns, respectively. The pulse duration used in these experiments is 
less than 2 ns, therefore the thermal and stress confinement conditions have been satisfied. 
3. Method 
3.1. PFC emulsions 
Monodisperse  PbS  nanoparticles  were  synthesized  [16], coated  with  silica  [17], [18],  and 
fluorinated  for  miscibilization  into  PFP  (Synquest)  [19].  All  chemicals  for  silica-coated 
nanoparticle synthesis and PFP solubilization were purchased from Sigma-Aldrich, and used 
as-received. Micrometer-scale, PbS-loaded PFP droplets were prepared using 5 mL deionized 
water, 0.15 mL PbS-PFP/PFP solution, and 0.03 mL anionic fluorosurfactant (Zonyl FSP, 
Sigma-Aldrich)  via  emulsification  using  polymer  membranes  (Whatman,  10  micron  pore 
size), following coarse emulsification by vortexing. 
PbS nanoparticles were imaged using a Hitachi HD-2000 scanning transmission electron 
microscope (TEM). PFC droplet sizes were measured using a Multisizer III Coulter counter 
(Beckman Coulter Inc., Fullerton, CA). The absorption coefficient of PbS-loaded PFP was 
determined using a Cary 6000i UV-vis-NIR spectrophotometer. PbS concentration of the PFP 
solution was determined using an Optima 3000 inductively coupled plasma atomic emission 
spectroscopy (ICP-AES) system. 
3.2. Photoacoustic microscope 
A modified SASAM 1000 scanning acoustic microscope (Kibero GmbH, Germany) was used 
for these experiments. It consists of an Olympus IX81 inverted optical microscope (Olympus, 
Japan) outfitted with an acoustic module installed above the optical objective for ultrasound 
measurements. A 1064 nm laser (Teem Photonics, France) was collimated through the back 
port of the microscope and focused onto the sample, allowing for simultaneous optical and 
photoacoustic measurements. Details of the system construction can be found elsewhere [20], 
[21]. 
The laser was focused to a 4 µm spot size using a 10x objective with a 0.3 numerical 
aperture, giving a laser fluence of up to 3.8 J/cm
2 per pulse. The laser had a pulse width of 700 
ps with an adjustable repetition frequency of up to 2 kHz. This laser was used for both the 
photoacoustic imaging and droplet vaporization. Two transducers were used for the acoustic 
and photoacoustic measurements. The 200 MHz transducer had a 60° aperture angle and −6 
dB bandwidth of 45%, while the 375 MHz transducer had a 60° aperture angle and a −6 dB 
bandwidth of 42%. 
All  photoacoustic  and  ultrasound  measurements  were  amplified  by  a  40  dB  amplifier 
(Miteq, USA) and digitized at a rate of 8 GHz (Acqiris, USA). For the ultrasound pulse-echo 
measurements, 10 Vpp pulses were generated at a pulse repetition frequency of up to 500 kHz 
using a monocycle pulse generator with a center frequency of 300 MHz and 100% bandwidth. 
For  photoacoustic  measurements,  the  transducers  were  used  passively  to  record  the 
photoacoustic  signals  by  synchronizing  the  receiver  to  the  laser  pulse.  The  overall  pulse 
repetition frequency in photoacoustic mode was limited by the repetition frequency of the 
laser, which was 2 kHz. 100-200 signals were averaged for each measurement to increase the 
signal-noise ratio (SNR). The signals  were then passed through a 110-800 MHz software 
bandpass filter to remove noise and enhance the SNR. 
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Droplets  were  diluted  with  water  in  a  chamber  slide  (Nunc,  Germany).  The  droplet 
concentration was diluted to ensure that droplets were sufficiently far apart from each other to 
probe them individually. The diameter of a single droplet was measured using the images 
recorded by the optical microscope and then each droplet was centered under the transducer. 
The laser and transducer were aligned for photoacoustic measurements. The transducer and 
laser position was kept constant while the microscope stage was scanned over a 15x15 µm 
area using a 0.5 µm step size, with the droplet located at the center. The laser fluence was 
increased, and the process repeated until vaporization occurred or the maximum laser fluence 
level was reached. 
PbS-loaded  PFP  droplets  were  measured  at  two  different  nanoparticle  loading  levels, 
designated “low” and “high”. The high loading contained double the nanoparticles of the low 
loading.  Ten  droplets  were  measured  at  each  PbS  loading  level  using  two  transducer 
frequencies, 200 and 375 MHz, for a total of 40 droplet measurements. Droplets were grouped 
into two categories, small (2-4 µm) and large (4-7 µm). A laser fluence ranging from 0.05 
J/cm
2 to 3.4 J/cm
2 was used, measured at the focal point using a Nova II laser power meter 
(Ophir, USA). 
The envelope of the signal at each x-y position of a single droplet was found by using the 
Hilbert transform of the recorded ultrasound data, from which the maximum signal amplitude 
was determined. Assuming the bulk droplet properties do not change with laser fluence, A(q) 
in Eq. (1) is constant. Therefore for a droplet irradiated with a known fluence F, Eq. (1) can 
be rewritten as 
  ( ) ( ) , p q B q F =    (4) 
where  B(q)  is  constant  at  a  specific  frequency.  Assuming  A(q)  is  constant  over  the  laser 
fluence range used, and the temperature increase over time was negligible, B(q) is the slope of 
the photoacoustic pressure measured as a function of laser fluence. In our measurements, the 
slope has units of V cm
2/J. The photoacoustic signal detected is proportional to pressure. 
Therefore, if the conversion factor between the voltage and pressure for the transducer was 
known, the slope would be proportional to the absorption coefficient µa, with units of cm
−1. 
C-scan images were made by quantizing the maximum photoacoustic signal from each x-y 
position of each droplet over an entire fluence range to grayscale values. The largest signal 
amplitude was assigned white, while the lowest signal amplitude was assigned black. The 
same dynamic range was used for all images. 
All  measurements  were  made  at  36°C  to  simulate  physiological  conditions  within  the 
human body. Occasionally bubbles would become dislodged from the substrate and float to 
the surface, therefore the transducer was examined after each droplet vaporization to ensure a 
bubble did not become lodged in the transducer cavity, which would strongly attenuate the 
ultrasound signals. 
4. Results 
4.1. Droplet configuration 
In this study, PbS nanoparticles were selected as the absorbing nanoparticle for integration 
into PFP, due to their high absorption coefficient in the infrared, ease of synthesis, and small 
size  permitting  high-yield  incorporation  into  micron-scale  PFP  droplets.  TEM  images 
demonstrate  good  monodispersity  of  silica-coated  PbS  nanoparticles  (10  nm  in  diameter, 
which included a 5 nm PbS core and a 2.5 nm thick silica shell, Fig. 1A), after miscibilization 
into PFP. The absorption coefficient of the PbS-loaded PFC solutions was 2.07 cm
−1 at low 
PbS loading, and 4.31 cm
−1 at high PbS loading at 1064 nm (Fig. 1B), measured using a 
spectrophotometer. The ratio of the  measured absorption coefficient at low and high PbS 
loadings for droplets in suspension was therefore 0.48. 
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low PbS loading, and 15.1 mg/mL PFC at high PbS loading as measured by ICP-AES, giving 
a low-high PbS loading ratio of 0.47, similar to the ratio determined using the absorption 
coefficients. 
The droplets in suspension ranged in diameter from approximately 1-12 µm, measured 
using a Multisizer III Coulter Counter. In the photoacoustic microscope, individual droplet 
diameters  were  determined  optically.  However  poor  optical  contrast  made  it  difficult  to 
accurately measure the diameter of small droplets, therefore droplets below approximately 2 
µm in diameter were not used in this study. Only droplets with diameters between 2 and 7 µm 
were used for these experiments. 
 
Fig. 1. (A) A TEM image of silica-coated PbS nanoparticles after miscibilization into PFC. The 
PbS nanoparticles were approximately 10 nm in diameter, composed of a 5 nm PbS core and a 
2.5 nm silica shell. The scale bar is 10 nm. (B) The absorption spectrum of droplets at low PbS 
loading (2.07 cm
−1 at 1064 nm, solid line) and high PbS loading (4.31 cm
−1 at 1064 nm, dotted 
line). 
4.2. Photoacoustic signals 
The photoacoustic signal c-scan of a single 6.9 µm diameter droplet with high PbS loading, 
measured at 200 MHz as a function of laser fluence is shown in Fig. 2. The signal amplitude 
increased  with increasing laser fluence, until vaporization occurred in the last frame.  The 
exact point of vaporization could be determined in the final frame (as indicated by the arrow), 
as no signal was detected following vaporization. No photoacoustic signal was detected from 
the resulting bubbles after vaporization. In addition, no photoacoustic signal was detected 
from unloaded PFP droplets at the fluences used. 
 
Fig. 2. Photoacoustic c-scan image sequence of a single 6.9 µm droplet with high PbS loading 
as a function of laser fluence, measured at 200 MHz. Intensity was normalized to maximum 
amplitude across all measurements and the same dynamic range was used for all images. An 
increase  in  the  photoacoustic  signal  was  observed  with  increasing  laser  fluence,  until 
vaporization occurred in the last frame as indicated by the arrow. The scale bar is 2.5 µm and is 
the same for all images. 
The photoacoustic signal amplitude from PFP droplets containing PbS nanoparticles was 
measured using 200 and 375 MHz transducers, at two different nanoparticle concentrations 
(low and high) and over a laser fluence range of 0.05 to 3.4 J/cm
2 using approximately a 0.25 
J/cm
2 step size. The signal amplitude was obtained from the central region of each droplet. 
The  slope  of  the  photoacoustic  signal  vs.  laser  fluence  is  proportional  to  the  absorption 
coefficient µa, as shown in Eq. (4). The measured photoacoustic signal vs. laser fluence for the 
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non-linearity  was  observed  above  approximately  2.0  J/cm
2,  therefore  these  measurements 
were not included in the slope calculations. 
 
Fig. 3. The photoacoustic signal vs. laser fluence for droplets measured at (A) low PbS loading 
at 200 MHz, (B) high PbS loading at 200 MHz, (C) low PbS loading at 375 MHz, and (D) high 
PbS loading at 375 MHz. A line of best fit is shown for each droplet, and the average slope is 
shown by the thick black line. 
Ten droplets were measured at each droplet configuration (low and high PbS loading at 
200 MHz, and low and high PbS loading at 375 MHz) for a total of forty droplets. The 
average slope over ten measurements is shown in Table 1 with standard deviation. The slope 
at low and high PbS loading was 0.0108 ± 0.0040 V cm
2/J and 0.0216 ± 0.0072 V cm
2/J at 
200 MHz, respectively, and 0.0042 ± 0.0017 V cm
2/J and 0.0062 ± 0.0013 V cm
2/J at 375 
MHz, respectively. The ratio of the slope at low and high PbS loadings was 0.50 at 200 MHz, 
and 0.68 at 375 MHz. The effect of droplet size on the slope was investigated by averaging 
the slope for small (2-4 µm) and large (4-7 µm) droplets. The ratio of the slope at low and 
high PbS loadings at 200 MHz was 0.52 for small droplets and 0.46 for large droplets, while 
the ratio at 375 MHz was 0.72 for small droplets and 0.65 for large droplets. These results are 
summarized in Table 1. 
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Nanoparticle 
Loading  Frequency (MHz) 
Slope (V cm
2/J) 
All droplets 
Slope (V cm
2/J) 
 2-4 µm droplets 
Slope (V cm
2/J) 
4-7 µm droplets 
Low  200  0.0108 ± 0.0040  0.0100 ± 0.0057  0.0111 ± 0.0035 
High  200  0.0216 ± 0.0072  0.0190 ± 0.0051  0.0242 ± 0.0085 
Low  375  0.0042 ± 0.0017  0.0044 ± 0.0023  0.0041 ± 0.0013 
High  375  0.0062 ± 0.0013  0.0061 ± 0.0016  0.0062 ± 0.0005 
Slope ratio 
Low-high loading  200  0.50  0.52  0.46 
Slope ratio 
Low-high loading  375  0.68  0.72  0.65 
4.3. Droplet vaporization 
Droplet vaporization was confirmed via optical and acoustic methods. Video sequences were 
recorded  during  bubble  expansion.  For  one  of  the  droplets,  an  initial  rapid  increase  in 
diameter from 4.5 µm to 19.5 µm was measured optically one second after vaporization (Fig. 
4), resulting in a radial expansion ratio of 4.3x. After this initial rapid expansion, the bubble 
diameter slowly increased over time. 
Twenty droplets were measured at each low and high PbS loading. Within the fluence 
thresholds of the experiment, eleven droplets were vaporized at low PbS loading (55%), while 
sixteen droplets were vaporized at high PbS loading (80%). The mean fluence level required 
to vaporize droplets at low PbS loading was 2.8 ± 0.5 J/cm
2 (minimum fluence 1.8 J/cm
2), and 
the  mean  fluence  required  to  vaporize  droplets  at  high  PbS  loading  was  2.7  ±  0.6 J/cm
2 
(minimum fluence 1.4 J/cm
2). 
Acoustic pulse echo measurements were made using a 375 MHz transducer to probe the 
bubble  during  expansion.  The  signal  from  the  glass  substrate  under  the  droplet  was 
approximately 250 mV while the droplet was in the liquid phase. The signal from the droplet 
itself was small and obscured within the substrate signal, as the transducers could not resolve 
the droplet and substrate signal due to the small droplet size. After vaporization, no signal 
from the  substrate  was detected; however a strong signal (200-300 mV)  from the bubble 
surface was measured. 
 
Fig. 4. Droplet vaporization observed via optical microscopy. The initial droplet size was 4.5 
µm (left). The bubble size was 19.5 µm one second after vaporization (right). The scale bar is 
30 µm. 
5. Discussion 
5.1. Droplet photoacoustic signals and optical absorption 
As discussed in section 3.3, the slope of the photoacoustic signal vs. laser fluence plot in Fig. 
3 is proportional to µa, assuming the bulk droplet properties remain constant for the laser 
fluences and number of laser exposures used. Two parameters are required to determine the 
absorption coefficient directly from the slope calculations. First, the relationship between the 
measured photoacoustic signal and pressure must be known. It is currently not possible to 
directly measure the pressure with ultra-high frequency transducers. Second, the variables in 
A(q) (Eq. (2) must be known at the frequencies and temperature used in this study. The sound 
velocity of PFC liquids have not been measured at 375 MHz, therefore a direct calculation is 
#144029 - $15.00 USDv Received 14 Mar 2011; revised 14 Apr 2011; accepted 26 Apr 2011; published 4 May 2011
(C) 2011 OSA 1 June 2011 / Vol. 2,  No. 6 / BIOMEDICAL OPTICS EXPRESS  1439not possible. In this work we compared the ratio of the slopes (which are proportional to the 
absorption  coefficient)  instead  of  calculating  and  comparing  the  absorption  coefficient 
directly. The ratio of the measured slope between low and high PbS loading should be equal 
to the ratio of the absorption coefficient between low and high PbS loading measured using a 
spectrophotometer. 
The low-high PbS loading ratio derived from the slope of the experimental measurements 
[Eq. (1)] was 0.50 at 200 MHz and 0.68 at 375 MHz, as shown in Table 1. The low-high PbS 
loading  ratio  was  0.48  determined  by  measuring  the  absorption  coefficient  using  a 
spectrophotometer,  and  0.47  determined  via  ICP.  The  loading  ratio  determined  via 
photoacoustic methods agrees with the loading ratio calculated by using the data collected 
using the 200 MHz transducer, but discrepancies were noted when loading ratio calculated by 
using the data collected using the 375 MHz transducer (Table 1). 
Several assumptions were made during these measurements. It is not known how the PbS 
nanoparticles  affect  the  bulk  PFC  properties.  Due  to  the  relatively  low  nanoparticle 
concentration in the PFC, the volume ratio of the nanoparticles compared to the PFC would be 
small, and the effect on the sound velocity, heat capacity and coefficient of thermal expansion 
in  Eq.  (1)  was  likely  negligible.  However  it  is  unknown  how  the  properties  vary  with 
ultrasound frequency. The sound velocity of PFC liquids have been measured at 10 MHz [22] 
and 250 MHz [23], it is unknown what degree of dispersion is present at higher frequencies. 
Therefore a direct comparison of the results at 200 and 375 MHz was difficult. 
There could be several reasons why the slopes calculated using data collected with the 200 
and 375 MHz transducers for the same loading are not similar. The sensitivity and SNR of the 
200 MHz transducer is higher than the 375 MHz transducer, as observed by the increased 
signal in the photoacoustic signal of Fig. 3 and percentage standard deviation. While the depth 
of field of both transducers is large in comparison to the droplet diameter (approximately 70 
µm and 40 µm for the 200 and 375 MHz transducers, respectively), the lateral resolution at 
200 MHz is 8 µm, in comparison to 4 µm at 375 MHz. Consequently the 375 MHz transducer 
is more sensitive to the focus position. 
Despite the difference in the slope ratio calculation between the two transducers, both 
measurements  showed  an  increase  in  the  slope,  indicating  an  increase  in  the  absorption 
coefficient  and  therefore  increase  in  the  optical  absorbing  agent  concentration  contained 
within the droplet. 
5.2. Photoacoustic signals from bubbles 
Photoacoustic signals were measured from droplets before vaporization as discussed in the 
previous  section.  Once  the  droplet  vaporized,  no  photoacoustic  signal  was  detected.  A 
pressure wave should be generated due to the rapid shell expansion that occurs during the 
phase change. In our measurements, 100-200 point averaging was used to improve the SNR. 
Since the pressure wave generated during the rapid expansion is a very fast event, the signal 
would  be  greatly  reduced  due  to  the  RF  signal  averaging.  Methods  are  currently  being 
investigated to detect this pressure wave. 
After vaporization, attempts were made to measure a photoacoustic signal from the bubble 
using the same method as with the droplets. No photoacoustic signal was detected from the 
bubbles. In droplet form, the nanoparticles would be suspended within the liquid core. During 
vaporization, the rapid expansion may force the nanoparticles towards the bubble shell, or 
possibly expel them outside the bubble. Since the bubble diameter is approximately 5x larger 
than the initial droplet diameter immediately following vaporization, the change in volume is 
approximately 125x. Therefore the nanoparticle concentration within the bubble or around the 
shell may be too dilute to generate a detectable photoacoustic signal. 
5.3. Droplet expansion 
Two expansion regimes were observed optically during the liquid to gas phase change during 
vaporization; an initial rapid expansion that occurred within one second, then a slow gradual 
expansion over a period of minutes. A 4.5 µm diameter droplet expanded to 19.5 µm within 
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similar to other studies using acoustic droplet vaporization, which have measured a radial 
increase of 5.3x [10] and 5.05x [24] for vaporization of micron-sized droplets, independent of 
initial droplet diameter. These experimental results agree with a radial expansion ratio of 5x 
predicted using ideal gas law calculations [10]. This expansion is likely due to the increase in 
volume during the liquid to gas phase change. The subsequent slow expansion observed over 
minutes has been hypothesized to be due to diffusion of gases between the coupling fluid and 
bubble [10]. 
Pulse echo measurements were used to verify a liquid-gas phase change after vaporization. 
The substrate signal under the liquid droplet was approximately 250 mV. After vaporization, a 
200-300  mV  signal  from  the  bubble  surface  was  measured  and  the  substrate  signal  was 
completely  attenuated.  The  strong  signal  from  the  bubble  surface  and  attenuation  of  the 
substrate signal under the droplet indicate that a phase change from liquid to gas occurred. 
5.4. Vaporization mechanism 
It  is  clear  by  both  the  change  in  droplet  volume  and  echogenicity,  that  the  liquid  PFC 
undergoes a phase transition to gas  upon laser irradiation above a threshold fluence. The 
mechanism  for optical droplet vaporization is not  well  understood. Vaporization could be 
thermally activated, where heating of the nanoparticles locally increases the temperature of 
the PFC past the boiling point, resulting in vaporization. Alternatively, the method could be 
acoustically driven, despite using an optical irradiation source. As a photoacoustic signal is 
detected  at  the  lower  fluence,  it  is  known  that  the  nanoparticles  act  as  very  small  but 
numerous acoustic sources from within the droplet. The mechanism could be similar to that 
observed during acoustic droplet vaporization, where above a certain peak negative pressure 
threshold vaporization occurs [10]. Our future work will examine both acoustic and optical 
droplet vaporization using the same platform, and could lead to a better understanding of 
droplet vaporization mechanisms. 
In this study, the average fluence required to achieve vaporization was 2.8 ± 0.5 J/cm
2 
with low PbS loading and 2.7 ± 0.6 J/cm
2 with high PbS loading. The average fluence was 
very similar for both loadings, however the minimum fluence level required to achieve droplet 
vaporization was 1.8 J/cm
2 with low PbS loading and 1.4 J/cm
2 with high PbS loading. There 
was a higher probability of vaporization at high PbS loading (80%) than low PbS loading 
(55%).  These  results  suggest  that  there  is  a  significant  variation  in  the  nanoparticle 
concentration  between  individual  droplets.  This  is  demonstrated  by  the  range  of  slopes 
observed in Fig. 3, and the  large standard deviation  in the average slope calculations. In 
addition, while the average fluence required for vaporization was similar for both loadings, 
the standard deviation was relatively high. Despite these variations, the slope ratio between 
low  and  high  PbS  loading  averaged  over  ten  droplets  showed  good  agreement  with  the 
absorption coefficient ratio measured directly. 
Our previous work using a higher nanoparticle concentration achieved vaporization using 
0.7 J/cm
2 [25]. By optimizing the optical absorption by changing the nanoparticle type, shape 
or concentration, lower vaporization fluence thresholds could be realized. Such modifications 
to nanoparticle composition are underway. 
5. Conclusion 
We demonstrate in this work a dual-mode contrast agent that can be used for photoacoustic 
and acoustic measurements. PbS nanoparticles were successfully incorporated into micron-
sized PFP droplets and the photoacoustic signal measured with 200 and 375 MHz transducers. 
The  photoacoustic  signal  generated  was  proportional  to  the  absorption  coefficient  of  the 
droplets. The minimum laser fluence required for conversion of the liquid droplet to a bubble 
(what  we  term  optical  droplet  vaporization)  was  1.4  J/cm
2  for  the  nanoparticle  type  and 
configuration  presented  here,  however  vaporization  was  not  achieved  for  all  droplets. 
Vaporization was confirmed by an increase in the ultrasound backscatter from the bubble 
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droplet. 
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